| abstract |
HBV replication inhibitors of formula (I), including their stereochemical isomeric forms, as well as their salts, hydrates, solvates, where R — R, B, and Z are as defined herein. The invention also relates to methods for producing said compounds, pharmaceutical compositions containing them, and their use alone or in combination with other HBV inhibitors in anti-HBV therapy. |